| 5VU0 | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | BMA, EDO, GAL, MAN, NA, NAG, PEG | enzyme |
| ||||||||||||
| Primary reference | Antibody fucosylation lowers FcgammaRIIIa/CD16a affinity by limiting the conformations sampled by the N162-glycan., Falconer DJ, Subedi GP, Marcella AM, Barb AW, ACS Chem Biol. 2018 Jul 17. doi: 10.1021/acschembio.8b00342. PMID:30016589 | ||||||||||||||
| Data retrieval |
![]() |
| View 5VU0 in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |